Darbufelone

This classification denotes a cyclooxygenase inhibitor with the molecular formula C18H24N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 72H8H6K34C, chemically known as 5-((z)-3,5-di-tert-butyl-4-hydroxybenzylidene)-2-imino-4-thiazolidinone. but generally known as darbufelone, which bears US NIH Compound Identifier 6444826. European Medicines Agency schedules Darbufelone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26843. The term DARBUFELONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule darbufelone under HS 29341000 and SITC 51579. As of Q4 2014, DARBUFELONE remains the US FDA Preferred Term for this commodity. Darbufelone bears US NLM identifiers UMLS ID C0969365 and NCI Concept Code C81061. SMILES: S1/C(=C\C2CC(C(C)(C)C)C(O)C(C(C)(C)C)C2)C(=O)N=C1N.